FeedworthyAI
Back to feed
GEN – Genetic Engineering and Biotechnology Newsnews

Chikungunya Vaccine Development in Africa Accelerated by ACT-CHIK

Monday, June 8, 2026Julianna LeMieux, PhDView original

ACT-CHIK is an EU-funded project (roughly $17 million) led by Institut Pasteur that will advance chikungunya vaccine trials across four African countries and prepare local manufacturing, strengthening vaccine access, outbreak preparedness, and regional production capacity.

The post Chikungunya Vaccine Development in Africa Accelerated by ACT-CHIK appeared first on GEN - Genetic Engineering and Biotechnology News.